Odyssey Group International, Inc. (ODYY)
USD 0.01
(-28.57%)
USD 0.01
(-28.57%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 2.14 Million USD | 40.0% |
| 2022 | 1.53 Million USD | 108.08% |
| 2021 | 736.24 Thousand USD | 166.78% |
| 2020 | 275.97 Thousand USD | -64.84% |
| 2019 | 784.91 Thousand USD | 24.26% |
| 2018 | 631.64 Thousand USD | 45.86% |
| 2017 | 433.04 Thousand USD | 127.71% |
| 2016 | 190.17 Thousand USD | 961.49% |
| 2015 | 17.91 Thousand USD | -92.52% |
| 2014 | 239.58 Thousand USD | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 1.48 Million USD | -36.81% |
| 2024 Q3 | 1.6 Million USD | 7.77% |
| 2024 Q1 | 2.35 Million USD | 9.59% |
| 2023 FY | 2.14 Million USD | 40.0% |
| 2023 Q4 | 2.14 Million USD | 12.72% |
| 2023 Q3 | 1.9 Million USD | 3.5% |
| 2023 Q1 | 1.62 Million USD | 6.4% |
| 2023 Q2 | 1.83 Million USD | 12.78% |
| 2022 Q3 | 1.56 Million USD | 10.46% |
| 2022 Q2 | 1.41 Million USD | 26.65% |
| 2022 Q1 | 1.11 Million USD | 51.57% |
| 2022 FY | 1.53 Million USD | 108.08% |
| 2022 Q4 | 1.53 Million USD | -1.87% |
| 2021 Q2 | 411.32 Thousand USD | 41.85% |
| 2021 Q3 | 675.84 Thousand USD | 64.31% |
| 2021 Q4 | 736.24 Thousand USD | 8.94% |
| 2021 Q1 | 289.97 Thousand USD | 5.07% |
| 2021 FY | 736.24 Thousand USD | 166.78% |
| 2020 FY | 275.97 Thousand USD | -64.84% |
| 2020 Q1 | 893.37 Thousand USD | 13.82% |
| 2020 Q4 | 275.97 Thousand USD | -75.52% |
| 2020 Q3 | 1.12 Million USD | 13.37% |
| 2020 Q2 | 994.56 Thousand USD | 11.33% |
| 2019 Q2 | 667.88 Thousand USD | -0.72% |
| 2019 Q4 | 784.91 Thousand USD | 9.85% |
| 2019 Q3 | 714.51 Thousand USD | 6.98% |
| 2019 FY | 784.91 Thousand USD | 24.26% |
| 2019 Q1 | 672.73 Thousand USD | 6.51% |
| 2018 FY | 631.64 Thousand USD | 45.86% |
| 2018 Q1 | 499.95 Thousand USD | 15.45% |
| 2018 Q2 | 565.68 Thousand USD | 13.15% |
| 2018 Q3 | 603.85 Thousand USD | 6.75% |
| 2018 Q4 | 631.64 Thousand USD | 4.6% |
| 2017 Q4 | 433.04 Thousand USD | 39.92% |
| 2017 FY | 433.04 Thousand USD | 127.71% |
| 2017 Q3 | 309.49 Thousand USD | 39.49% |
| 2017 Q2 | 221.88 Thousand USD | 13.13% |
| 2017 Q1 | 196.13 Thousand USD | 3.13% |
| 2016 FY | 190.17 Thousand USD | 961.49% |
| 2016 Q1 | 38.22 Thousand USD | 113.37% |
| 2016 Q4 | 190.17 Thousand USD | 3.15% |
| 2016 Q3 | 184.36 Thousand USD | 93.45% |
| 2016 Q2 | 95.3 Thousand USD | 149.32% |
| 2015 FY | 17.91 Thousand USD | -92.52% |
| 2015 Q4 | 17.91 Thousand USD | 0.62% |
| 2015 Q1 | 121.59 Thousand USD | 0.0% |
| 2015 Q3 | 17.8 Thousand USD | -65.82% |
| 2015 Q2 | 52.09 Thousand USD | -57.16% |
| 2014 FY | 239.58 Thousand USD | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Manhattan Scientifics, Inc. | 60 Thousand USD | -3474.433% |
| SS Innovations International, Inc. | 8.21 Million USD | 73.904% |
| Össur hf. | 467.73 Million USD | 99.541% |
| Össur hf. | 467.73 Million USD | 99.541% |
| CVR Medical Corp. | - USD | -Infinity% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| QHSLab, Inc. | 1.78 Million USD | -20.382% |
| BrainsWay Ltd. | 471 Thousand USD | -355.342% |
| BioElectronics Corporation | 14.83 Million USD | 85.54% |
| AVITA Medical, Inc. | 449.48 Thousand USD | -377.139% |
| Zecotek Photonics Inc. | 3.22 Million USD | 33.434% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| Wellstar International, Inc. | 51.36 Million USD | 95.825% |
| Hamilton Thorne Ltd. | 27.81 Million USD | 92.288% |
| EKF Diagnostics Holdings plc | 5.21 Million USD | 58.899% |
| Escalon Medical Corp. | 524.71 Thousand USD | -308.725% |
| Aurora Spine Corporation | 2.67 Million USD | 19.692% |
| NewCardio, Inc. | 3 Million USD | 28.511% |
| Avitar, Inc. | 5.26 Million USD | 59.267% |
| Vivos Inc. | - USD | -Infinity% |
| Theraclion SA | 1.95 Million EUR | -9.941% |
| Kelyniam Global, Inc. | 496.39 Thousand USD | -332.044% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| REMSleep Holdings, Inc. | 178.11 Thousand USD | -1104.094% |
| Positron Corporation | 1.78 Million USD | -19.979% |
| CYduct Diagnostics, Inc. | 670 Thousand USD | -220.099% |
| Nanomix Corporation | 11.4 Million USD | 81.198% |
| Wellness Center USA, Inc. | 4.04 Million USD | 46.94% |
| Stratec SE | 156.16 Million USD | 98.627% |
| Heart Tronics, Inc. | 209.28 Thousand USD | -924.756% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Nu-Med Plus, Inc. | 100 Thousand USD | -2044.66% |
| Electromedical Technologies, Inc. | 1.69 Million USD | -26.264% |
| Lombard Medical, Inc. | 32.29 Million USD | 93.359% |
| ALR Technologies Inc. | 19.26 Million USD | 88.867% |
| MicroPort Scientific Corporation | 1.69 Billion USD | 99.874% |
| Vycor Medical, Inc. | 1.11 Million USD | -93.169% |
| VMS Rehab Systems, Inc. | 133.52 USD | -1606146.255% |
| Perimeter Medical Imaging AI, Inc. | 192.89 Thousand USD | -1011.833% |
| Guided Therapeutics, Inc. | 2.05 Million USD | -4.211% |
| SANUWAVE Health, Inc. | 31.94 Million USD | 93.286% |
| Ingen Technologies, Inc. | 631.15 Thousand USD | -239.798% |
| United American Healthcare Corporation | - USD | -Infinity% |
| IR-Med Inc. | 161 Thousand USD | -1232.087% |
| Polarean Imaging plc | 216.38 Thousand USD | -891.132% |
| ECGI Holdings, Inc. | 3.17 Million USD | 32.372% |
| Capital Group Holdings, Inc. | 4944.00 USD | -43279.045% |
| ADM Tronics Unlimited, Inc. | 799.65 Thousand USD | -168.197% |
| Medical Supply International USA, Inc. | 227 Thousand USD | -844.776% |
| Urologix, Inc. | 5.33 Million USD | 59.785% |
| Rapid Therapeutic Science Laboratories, Inc. | 3.83 Million USD | 44.014% |
| Nexeon MedSystems Inc. | 4.21 Million USD | 49.121% |
| Qualis Innovations, Inc. | 9102.00 USD | -23462.514% |
| Smith & Nephew plc | 3.07 Billion USD | 99.93% |
| NIOX Group Plc | 1.4 Million USD | -53.157% |
| Fuse Medical, Inc. | 1.99 Million USD | -7.574% |
| Broncus Holding Corporation | 2.35 Million USD | 8.907% |
| Brain Scientific Inc. | 2.86 Million USD | 25.103% |
| Pressure BioSciences, Inc. | 22.75 Million USD | 90.576% |
| Health Logic Interactive Inc. | 40.44 Thousand USD | -5203.051% |